Search

Your search keyword '"Bucki, R."' showing total 286 results

Search Constraints

Start Over You searched for: Author "Bucki, R." Remove constraint Author: "Bucki, R."
286 results on '"Bucki, R."'

Search Results

101. Biocompatible Materials in Otorhinolaryngology and Their Antibacterial Properties.

102. Hypogelsolinemia and Decrease in Blood Plasma Sphingosine-1-Phosphate in Patients Diagnosed with Severe Acute Pancreatitis.

103. Extracellular Vimentin as a Target Against SARS-CoV-2 Host Cell Invasion.

104. Targeting bacteria causing otitis media using nanosystems containing nonspherical gold nanoparticles and ceragenins.

105. Targeting the Gut Microbiota to Relieve the Symptoms of Irritable Bowel Syndrome.

106. Ceragenin-Coated Non-Spherical Gold Nanoparticles as Novel Candidacidal Agents.

107. Peanut-Shaped Gold Nanoparticles with Shells of Ceragenin CSA-131 Display the Ability to Inhibit Ovarian Cancer Growth In Vitro and in a Tumor Xenograft Model.

108. Assessment of Ceragenins in Prevention of Damage to Voice Prostheses Caused by Candida Biofilm Formation.

109. Inhomogeneity of stiffness and density of the extracellular matrix within the leukoplakia of human oral mucosa as potential physicochemical factors leading to carcinogenesis.

110. Varied-shaped gold nanoparticles with nanogram killing efficiency as potential antimicrobial surface coatings for the medical devices.

111. Tumor stiffening reversion through collagen crosslinking inhibition improves T cell migration and anti-PD-1 treatment.

112. Nanomechanical Hallmarks of Helicobacter pylori Infection in Pediatric Patients.

113. Bactericidal Properties of Rod-, Peanut-, and Star-Shaped Gold Nanoparticles Coated with Ceragenin CSA-131 against Multidrug-Resistant Bacterial Strains.

114. Extracellular vimentin as a target against SARS-CoV-2 host cell invasion.

115. Rod-shaped gold nanoparticles exert potent candidacidal activity and decrease the adhesion of fungal cells.

116. Physics Comes to the Aid of Medicine-Clinically-Relevant Microorganisms through the Eyes of Atomic Force Microscope.

117. Bacteria Residing at Root Canals Can Induce Cell Proliferation and Alter the Mechanical Properties of Gingival and Cancer Cells.

118. Tissue Rheology as a Possible Complementary Procedure to Advance Histological Diagnosis of Colon Cancer.

119. Two Lineages of Pseudomonas aeruginosa Filamentous Phages: Structural Uniformity over Integration Preferences.

120. Biofilm Growth Causes Damage to Silicone Voice Prostheses in Patients after Surgical Treatment of Locally Advanced Laryngeal Cancer.

121. A multiscale biophysical model for the recruitment of actin nucleating proteins at the membrane interface.

122. Recombinant Human Plasma Gelsolin Stimulates Phagocytosis while Diminishing Excessive Inflammatory Responses in Mice with Pseudomonas aeruginosa Sepsis.

123. Antimicrobial and Physicochemical Properties of Artificial Saliva Formulations Supplemented with Core-Shell Magnetic Nanoparticles.

124. Nanoantibiotics containing membrane-active human cathelicidin LL-37 or synthetic ceragenins attached to the surface of magnetic nanoparticles as novel and innovative therapeutic tools: current status and potential future applications.

125. Expression and Function of Host Defense Peptides at Inflammation Sites.

126. Toxicity of parasites and their unconventional use in medicine.

127. Loss of Vimentin Enhances Cell Motility through Small Confining Spaces.

128. Decreased Activity of Blood Acid Sphingomyelinase in the Course of Multiple Myeloma.

129. The Influence of Mucin-Based Artificial Saliva on Properties of Polycaprolactone and Polylactide.

130. Early central vs. peripheral immunological and neurobiological effects of fingolimod-a longitudinal study.

131. Susceptibility of microbial cells to the modified PIP 2 -binding sequence of gelsolin anchored on the surface of magnetic nanoparticles.

132. Artificial Saliva: Challenges and Future Perspectives for the Treatment of Xerostomia.

133. Use of ceragenins as a potential treatment for urinary tract infections.

134. PhSeZnCl in the Synthesis of Steroidal β-Hydroxy-Phenylselenides Having Antibacterial Activity.

135. Lateral distribution of phosphatidylinositol 4,5-bisphosphate in membranes regulates formin- and ARP2/3-mediated actin nucleation.

136. Hypogelsolinemia in Patients Diagnosed with Acute Myeloid Leukemia at Initial Stage of Sepsis.

137. Defective Sphingolipids Metabolism and Tumor Associated Macrophages as the Possible Links Between Gaucher Disease and Blood Cancer Development.

138. Inhibition of inflammatory response in human keratinocytes by magnetic nanoparticles functionalized with PBP10 peptide derived from the PIP2-binding site of human plasma gelsolin.

139. Regulation of actin assembly by PI(4,5)P2 and other inositol phospholipids: An update on possible mechanisms.

140. Plasma Gelsolin: Indicator of Inflammation and Its Potential as a Diagnostic Tool and Therapeutic Target.

141. Pathophysiological implications of actin-free Gc-globulin concentration changes in blood plasma and cerebrospinal fluid collected from patients with Alzheimer's disease and other neurological disorders.

142. Ceragenin CSA-13 as free molecules and attached to magnetic nanoparticle surfaces induce caspase-dependent apoptosis in human breast cancer cells via disruption of cell oxidative balance.

143. The Role of Oral Cavity Biofilm on Metallic Biomaterial Surface Destruction-Corrosion and Friction Aspects.

144. Unexpected profile of sphingolipid contents in blood and bone marrow plasma collected from patients diagnosed with acute myeloid leukemia.

145. Soft Substrates Containing Hyaluronan Mimic the Effects of Increased Stiffness on Morphology, Motility, and Proliferation of Glioma Cells.

146. Stiffening of bacteria cells as a first manifestation of bactericidal attack.

148. Development of antifungal therapies using nanomaterials.

149. Anaerobic bacteria growth in the presence of cathelicidin LL-37 and selected ceragenins delivered as magnetic nanoparticles cargo.

150. Formulation and candidacidal activity of magnetic nanoparticles coated with cathelicidin LL-37 and ceragenin CSA-13.

Catalog

Books, media, physical & digital resources